Vegetarian Diet and Innate Immunity in Patients With Myocardial Infarction and in Healthy Volunteers (FRESH-MI Study)
- Disease/Condition
- Myocardial Infarction
- Drug/Device/Intervention
- Vegetarian diet
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Radboud University Medical Center
- Location
- Nijmegen, Netherlands
- Phase
- N/A
- Start date
- Jan 08, 2024
- End date
- Sep 01, 2026
- Enrollment
- 120 participants
The difference in cytokine production capacity (including TNF-α, IL-6, IL-10, IL-1β) of isolated peripheral blood mononuclear cells (PBMCs) after ex-vivo stimulation before and after the vegetarian diet compared to the habitual diet in patients with AMI
The goal of this clinical trial is to assess the effect of a vegetarian diet on innate
 immunity of patients with a recent acute myocardial infarction and healthy participants.
 Also, we will assess the willingness to adapt a more vegetarian eating habit. Study subjects
 will follow a vegetarian diet for five weeks, whereafter a stabilisation period of six weeks
 will follow. Then, participants will follow to the other dietary intervention for five weeks.
 Blood will be drawn at given time points to analyse inflammatory parameters.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06209723
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06209723 through Pure Global AI's free database. This phase not specified trial is sponsored by Radboud University Medical Center and is currently Recruiting. The study focuses on Myocardial Infarction. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.